Key facts
- This page summarizes John R. Palumbo's Form 4 filing for DarioHealth Corp. (DRIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Sep 2026, 16:07.
John R. Palumbo - 24 Sep 2026 Form 4 Insider Report for DarioHealth Corp. (DRIO)
- Reporting relationship
- Director
- Issuer ticker
- DRIO
- Reported as of
- 24 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Sep 2026, 16:07:33 UTC
- Prior SEC filing
- 13 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Palumbo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John R. Palumbo filed Form 4 for DarioHealth Corp. (DRIO) on 28 Sep 2026.
Change
- Previous filing in this sequence was filed on 13 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001251475
Primary reporting owner
PALUMBO JOHN R
- Relationship
- Director
- Address
- 322 W 57TH STREET, #33B18, NEW YORK
- Signature
- /s/ John Palumbo
- Signature date
- 28 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DRIO
transaction
Common stock
Award
- Transaction value
- Shares
- +62,000
- Change %
- +1378%
- Price
- $0.000000*
- Shares after
- 66,500
- Date
- 24 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted share award shall vest on the second anniversary of the grant date.